The Pfizer-BioNTech COVID-19 vaccine will be produced in South Africa for the first time, the company announced Wednesday.
The Cape Town-based Biovac Institute will produce the vaccine for Pfizer starting in 2022, the Associated Press reported. The company will distribute the vaccine throughout Africa.
As cases surge, Africa has struggled to obtain more vaccine doses. Biovac set a goal of creating 100 million doses annually.
Vaccinations in South Africa have increased, with 1.4 million people being fully vaccinated. Over 220,000 people are getting COVID-19 shots on weekdays, per AP. The country hopes that 67% of its population will be vaccinated by February 2022.